Globus Medical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Globus Medical and other ETFs, options, and stocks.

About GMED

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. It engages in developing products that promote healing in patients with musculoskeletal disorders. 

CEO
Keith W. Pfeil
CEOKeith W. Pfeil
Employees
6,000
Employees6,000
Headquarters
Audubon, Pennsylvania
HeadquartersAudubon, Pennsylvania
Founded
2003
Founded2003
Employees
6,000
Employees6,000

GMED Key Statistics

Market cap
11.69B
Market cap11.69B
Price-Earnings ratio
22.26
Price-Earnings ratio22.26
Dividend yield
Dividend yield
Average volume
1.00M
Average volume1.00M
High today
$87.92
High today$87.92
Low today
$86.49
Low today$86.49
Open price
$86.68
Open price$86.68
Volume
463.57K
Volume463.57K
52 Week high
$101.40
52 Week high$101.40
52 Week low
$51.79
52 Week low$51.79

Stock Snapshot

As of today, Globus Medical(GMED) shares are valued at $86.59. The company's market cap stands at 11.69B, with a P/E ratio of 22.26.

On 2026-03-26, Globus Medical(GMED) stock moved within a range of $86.49 to $87.92. With shares now at $86.59, the stock is trading +0.1% above its intraday low and -1.5% below the session's peak.

Trading activity shows a volume of 463.57K, compared to an average daily volume of 1M.

The stock's 52-week range extends from a low of $51.79 to a high of $101.40.

The stock's 52-week range extends from a low of $51.79 to a high of $101.40.

GMED News

Nasdaq 8h
Should You Retain Henry Schein Stock in Your Portfolio for Now?

Henry Schein, Inc.’s HSIC joint venture, Henry Schein One, is driving strong growth in its core products and introducing new solutions. The company’s robust par...

Should You Retain Henry Schein Stock in Your Portfolio for Now?
Simply Wall St 1d
A Look At Globus Medical Valuation After Recent Pullback And Mixed Return Profile

Advertisement Stock performance snapshot and business profile Globus Medical (GMED) is on investors’ radar after a recent pullback, with the stock showing a 1...

A Look At Globus Medical Valuation After Recent Pullback And Mixed Return Profile
TipRanks 3d
Globus Medical Announces Board Resignation, Affirms Governance Stability

Globus Medical ( (GMED) ) has issued an announcement. On March 23, 2026, Globus Medical announced that board member John A. DeFord, Ph.D., resigned from its Bo...

Analyst ratings

69%

of 16 ratings
Buy
68.8%
Hold
31.3%
Sell
0%

More GMED News

Simply Wall St 5d
Is It Time To Reassess Globus Medical After Its Recent 17% One-Year Gain?

If you are wondering whether Globus Medical's current share price reflects its true worth, the key pieces of the valuation puzzle can help you frame that decisi...

Is It Time To Reassess Globus Medical After Its Recent 17% One-Year Gain?
Nasdaq 6d
Should You Continue to Hold Insulet Stock in Your Portfolio?

Insulet PODD is well-poised to grow in the upcoming quarters, owing to its strong momentum for the Omnipod 5 automated insulin delivery (“AID”) system for both...

Should You Continue to Hold Insulet Stock in Your Portfolio?

People also own

Based on the portfolios of people who own GMED. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.